Interoperable tech-enabled services by clinical experts empower health plans to better manage members’ medications across care continuum, enhancing patient safety and reducing readmissions
Tallahassee – October 3, 2024 – ActualMeds, the industry leader in patient-centered medication management, today unveiled the company’s newest tech-enabled service to help health plans promote successful transitions of care and reduce unnecessary readmissions for Medicare Advantage members. The solution, which is now commercially available, arose from customer interest in addressing a pressing need to reduce higher than average readmission rates for members in three chronic disease populations: heart failure; diabetes; and COPD.
While numerous studies and literature reviews have demonstrated that that pharmacist-conducted medication reconciliation at the time of discharge from acute care can reduce the rate of readmissions, most organizations lack the clinical and care coordination resources, as well as access to all relevant patient data, to perform a best practice medication reconciliation.
ActualMeds is well equipped to deliver a medication reconciliation solution at scale and address these challenges because the company’s InConcert Medication Management (ICCM) technology powers an in-house team of highly experienced clinical pharmacists backed up by member care coordinators, to enable high-touch service that is cost-effective and delivers proven results. Patients’ longitudinal medication histories are maintained by the ICMM platform and follow them across care settings. Then, patients’ medication and medical histories are validated by matching prescriber’s orders at admission and discharge with near real-time claims and fills to identify potential duplications of therapy or medication omissions that often contribute to readmissions to acute care.
“Helping health plans to improve transitions of care and medication reconciliation is an incredibly important issue that we’re pleased to be at the forefront of addressing with our customers. Our solution offers a critical missing piece of the care puzzle. By providing both interoperable data and clinical experts, we can not only reduce the burdens of medication reconciliation on nurses and pharmacists, but also reduce the risk of readmissions – an outcome that is better for patients and can be scaled,” said Patricia Meisner, Co-founder and CEO of ActualMeds.
About ActualMeds
For more than a decade, ActualMeds has paved the way in automating clinical best practices for comprehensive medication review and medication reconciliation. The company brings a wealth of subject matter expertise in interoperability, artificial intelligence, and robotic process automation as well as deep clinical expertise to create seamless medication management for patients and their care teams across all post-acute care settings. ActualMeds’ patient-centric approach creates measurable impact on patient outcomes, reported satisfaction and quality scores, as well as lowering care management expenses and total cost of care. Healthcare organizations can become more efficient, increase access to quality care, reduce employment overhead costs, prevent mistakes, and deliver better outcomes for themselves, and their patients with the support of the company’s technology-enabled solutions. The innovative platform with highly structured, precise protocols drives scalable high-touch interactions that result in meaningful patient activation, elimination of barriers, and problem resolution to drive patient engagement and promote adherence. Learn more at www.actualmeds.com today.
